Oliver Luxxe Assets’s Zimmer Biomet ZBH Stock Holding History

Oliver Luxxe Assets’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-27,617	Closed	-$4.31M	–	217
2021 Q2	$4.31M	Buy	27,617 +303	+1%	+$49.1K	1.18%	19
2021 Q1	$4.25M	Buy	27,314 +840	+3%	+$130K	1.27%	15
2020 Q4	$4.09M	Sell	26,474 -18	-0.1%	-$2.54K	1.28%	13
2020 Q3	$3.5M	Buy	26,492 +443	+2%	+$57.9K	1.3%	17
2020 Q2	$3.02M	Buy	26,049 +300	+1%	+$34.6K	1.59%	18
2020 Q1	$2.78M	Buy	25,749 +6,390	+33%	+$838K	1.74%	16
2019 Q4	$2.81M	Buy	19,359 +11,182	+137%	+$1.54M	1.47%	24
2019 Q3	$1.05M	Buy	8,177 +3,341	+69%	+$432K	0.61%	53
2019 Q2	$567K	Buy	+4,836	New	+$566K	0.31%	83

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Oliver Luxxe Assets's ZBH Position: Q3 2021 in Review

Oliver Luxxe Assets sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 27,617 shares — an estimated $4.31M sold.

Oliver Luxxe Assets first reported a position in ZBH in Q2 2019 and held it in 9 quarters. The position peaked at $4.31M in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

Oliver Luxxe Assets reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
Oliver Luxxe Assets sold 27,617 Zimmer Biomet shares in Q3 2021, an estimated $4.31M.
Oliver Luxxe Assets first reported a position in Zimmer Biomet in Q2 2019 and held it in 9 quarters.
Oliver Luxxe Assets's Zimmer Biomet position peaked at $4.31M in Q2 2021.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Oliver Luxxe Assets's 13F filing for Q3 2021, filed 10 Nov 2021.